CLINICAL TRIAL SUPPLY CHAIN OPTIMIZATION

Day 1: 22nd September 2026

Integrating Operations, Digital Innovation, AI-Driven Forecasting, and Strategic Partnerships for Resilient, Patient-Centric, and Globally Compliant Trial Delivery

INTERACTIVE PANEL DISCUSSION

09:00 Optimizing End-to-End Clinical Trial Supply Chains in a Decentralized Trial Environment

This panel explores how decentralized and hybrid clinical trial models are reshaping supply chain strategies, emphasizing the need to manage global logistics complexity, ensure temperature-controlled distribution for sensitive therapies, and leverage digital platforms for real-time visibility. It also highlights solutions for last-mile delivery to remote patients, improved integration between clinical and supply chain teams, and balancing cost efficiency with regulatory compliance and patient-centric approaches.

Discussion Topics:

  • Managing logistics complexity introduced by decentralized and hybrid clinical trial models across regions

  • Ensuring temperature-controlled distribution for biologics and advanced therapy medicinal products globally

  • Leveraging digital platforms for real-time supply chain visibility and proactive risk mitigation

  • Addressing last-mile delivery challenges to patients participating remotely in clinical trials

  • Integrating clinical operations and supply chain teams for synchronized trial execution

  • Balancing cost efficiency while maintaining compliance and patient-centric delivery strategies

FROM SILOS TO SYNERGY

10:30 Transforming Clinical Trial Execution Through Integrated Supply Chain and Operations, Shared Data Platforms, and Cross-Functional Governance

This talk explores how integrating clinical trial supply chain planning with clinical operations can significantly improve execution and outcomes. It highlights the importance of strengthening communication between traditionally siloed teams and leveraging shared data platforms to enable synchronized planning and real-time decision-making. Attendees will learn practical approaches to reducing delays caused by misalignment between operational and supply activities, while implementing cross-functional governance structures that support faster, more informed decisions. The session also examines how to measure the impact of this integration on trial timelines, efficiency, and overall success rates, offering actionable insights for organizations aiming to modernize and streamline their clinical trial processes.

10:55 Questions & Discussion

11:00 Morning Break

INTERACTIVE PANEL DISCUSSION

11:30 Leveraging Artificial Intelligence and Predictive Analytics in Clinical Supply Chain Forecasting

This panel explores how artificial intelligence and predictive analytics are transforming clinical supply chain forecasting. Experts will discuss leveraging machine learning to enhance demand accuracy, integrating historical and real-time data for adaptive planning, minimizing waste through optimized inventory and expiry management, and accelerating decisions via automated analytics. The session also addresses data quality challenges and ensuring AI-driven outputs remain aligned with regulatory and compliance standards.

Discussion Topics:

  • Applying machine learning models to improve demand forecasting accuracy across clinical trial phases

  • Integrating historical trial data with real-time inputs for dynamic supply planning adjustments

  • Reducing waste through optimized inventory levels and expiry management using predictive insights

  • Enhancing decision-making speed through automated analytics dashboards and reporting tools

  • Addressing data quality challenges that impact predictive model performance and reliability

  • Aligning AI-driven forecasting outputs with regulatory and quality compliance requirements

13:00 Lunch Break

INTERACTIVE PANEL DISCUSSION

14:00 Vendor Management and Strategic Partnerships in Clinical Trial Supply Chain Ecosystems

This interactive panel explores best practices in vendor management and strategic partnerships within clinical trial supply chains. It highlights vendor selection based on quality, reliability, and global capability, alongside the use of performance metrics to ensure consistent outcomes. The discussion emphasizes collaborative partnerships to drive innovation, proactive risk management through audits, and aligning vendor strategies with clinical timelines to strengthen resilience and global reach.

Discussion Topics:

  • Selecting and qualifying vendors based on quality, reliability, and global operational capabilities

  • Establishing performance metrics and service level agreements to ensure consistent delivery outcomes

  • Building collaborative partnerships to enhance innovation and problem-solving capabilities

  • Managing vendor risks through regular audits and performance reviews

  • Aligning vendor strategies with clinical development timelines and organizational objectives

  • Leveraging strategic partnerships to expand global reach and improve supply chain resilience

15:30 Afternoon Break

TEMPERATURE CONTROLLED PACKAGING

16:00 Design and validation of temperature controlled packaging solutions for biologics and advanced therapy medicinal products in clinical trials

Key points

  • Selection criteria for passive versus active thermal packaging systems

  • Thermal qualification protocols under ISTA and GDP aligned conditions

  • Impact of biologics sensitivity on packaging design and stability requirements

  • Lane risk assessment including ambient profiles and transit duration variability

  • Lifecycle management of reusable packaging and sustainability considerations

16:25 Questions & Discussion

ADVANCED THERAPY LOGISTICS

16:30 Cold Chain Logistics Innovations for Advanced Therapies and Biologics in Clinical Trials

  • Addressing ultra-low temperature requirements for cell and gene therapies distribution globally

  • Evaluating new packaging technologies that maintain product integrity during extended transit times

  • Monitoring temperature excursions using IoT-enabled smart sensors and real-time alerts

  • Ensuring compliance with Good Distribution Practice guidelines across multiple jurisdictions

  • Training logistics partners on handling sensitive biologics and personalized medicine products

  • Balancing cost implications of advanced cold chain solutions with clinical trial budget constraints

16:55 Questions & Discussion

17:00 End of Day One